​

Arcellx (ACLX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

ACLX Stock Forecast

Arcellx (ACLX) stock forecast, based on 13 Wall Street analysts, predicts a 12-month average price target of $111.60, with a high of $122.00 and a low of $95.00. This represents a 83.89% increase from the last price of $60.69.

$50 $65 $80 $95 $110 $125 High: $122 Avg: $111.6 Low: $95 Last Closed Price: $60.69

ACLX Stock Rating

Arcellx stock's rating consensus is Buy, based on 13 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 13 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 13 0 13 Strong Sell Sell Hold Buy Strong Buy

ACLX Price Target Upside V Benchmarks

TypeNameUpside
StockArcellx83.89%
SectorHealthcare Stocks 33.91%
IndustryBiotech Stocks 83.49%

Price Target Trends

1M3M12M
# Anlaysts--8
Avg Price Target--$99.50
Last Closing Price$60.69$60.69$60.69
Upside/Downside--63.95%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25613---19
Mar, 25613---19
Feb, 25613---19
Jan, 25613---19
Dec, 24613---19
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 08, 2024Biren AminPiper Sandler$115.00$101.0913.76%89.49%
Nov 06, 2024Jack AllenRobert W. Baird$106.00$86.0923.13%74.66%
Nov 06, 2024Emily BodnarH.C. Wainwright$95.00$86.0910.35%56.53%
Oct 29, 2024Cory KasimovEvercore ISI$120.00$84.9941.19%97.73%
Oct 18, 2024Ben BurnettStifel Nicolaus$122.00$95.2728.06%101.02%
May 31, 2024Biren AminPiper Sandler$70.00$52.2434.00%15.34%
May 15, 2024Benjamin BurnettStifel Nicolaus$83.00$50.6263.97%36.76%
May 13, 2024Cory KasimovEvercore ISI$85.00$49.7770.79%40.06%
Mar 18, 2024Gil BlumNeedham$81.00$69.1117.20%33.47%
Dec 12, 2022Needham$35.00$28.8521.32%-42.33%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 09, 2024BenchmarkPositivePositivehold
Nov 08, 2024Piper SandlerOverweightOverweighthold
Nov 06, 2024CitigroupBuyBuyhold
Nov 05, 2024Bank of America SecuritiesBuyBuyhold
Oct 29, 2024Evercore ISIOutperformOutperformhold
Oct 18, 2024NeedhamBuyBuyhold
Sep 03, 2024Cantor FitzgeraldOverweightinitialise
Jul 22, 2024Piper SandlerBuyBuyhold
Jun 18, 2024NeedhamUnderperformUnderperformhold
May 31, 2024Stifel NicolausBuyBuyhold

Financial Forecast

EPS Forecast

$-15 $-11 $-7 $-3 $1 $5 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-4.22$-1.47$-2.00----
Avg Forecast$-5.24$-2.47$-1.61$-2.28$-2.61$-2.29$-0.34
High Forecast$-2.80$-2.11$-1.00$0.88$0.12$0.74$-0.12
Low Forecast$-10.68$-3.00$-2.04$-4.16$-5.29$-5.02$-0.79
Surprise %-19.47%-40.49%24.22%----

Revenue Forecast

$0 $180M $360M $540M $720M $900M Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported-$110.32M$107.94M----
Avg Forecast$2.14M$67.53M$121.71M$119.48M$183.55M$243.09M$435.02M
High Forecast$3.86M$73.27M$132.76M$198.36M$183.55M$249.62M$882.63M
Low Forecast$1.38M$61.77M$112.49M$61.73M$183.55M$236.55M$220.63M
Surprise %-63.36%-11.32%----

Net Income Forecast

$-550M $-430M $-310M $-190M $-70M $50M Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-186.10M$-70.69M$-107.35M----
Avg Forecast$-251.66M$-122.89M$-73.02M$-135.07M$-138.71M$-158.05M$-16.27M
High Forecast$-134.62M$-101.48M$-47.87M$42.07M$5.68M$35.45M$-5.85M
Low Forecast$-513.26M$-144.29M$-98.18M$-200.08M$-254.27M$-241.47M$-38.04M
Surprise %-26.05%-42.48%47.00%----

ACLX Forecast FAQ

Is Arcellx stock a buy?

Arcellx stock has a consensus rating of Buy, based on 13 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 13 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Arcellx is a favorable investment for most analysts.

What is Arcellx's price target?

Arcellx's price target, set by 13 Wall Street analysts, averages $111.6 over the next 12 months. The price target range spans from $95 at the low end to $122 at the high end, suggesting a potential 83.89% change from the previous closing price of $60.69.

How does Arcellx stock forecast compare to its benchmarks?

Arcellx's stock forecast shows a 83.89% upside, outperforming the average forecast for the healthcare stocks sector (33.91%) and outperforming the biotech stocks industry (83.49%).

What is the breakdown of analyst ratings for Arcellx over the past three months?

  • April 2025: 31.58% Strong Buy, 68.42% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 31.58% Strong Buy, 68.42% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 31.58% Strong Buy, 68.42% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Arcellx’s EPS forecast?

Arcellx's average annual EPS forecast for its fiscal year ending in December 2025 is $-2.28, marking a 14.00% increase from the reported $-2 in 2024. Estimates for the following years are $-2.61 in 2026, $-2.29 in 2027, and $-0.34 in 2028.

What is Arcellx’s revenue forecast?

Arcellx's average annual revenue forecast for its fiscal year ending in December 2025 is $119.48M, reflecting a 10.70% increase from the reported $107.94M in 2024. The forecast for 2026 is $183.55M, followed by $243.09M for 2027, and $435.02M for 2028.

What is Arcellx’s net income forecast?

Arcellx's net income forecast for the fiscal year ending in December 2025 stands at $-135M, representing an 25.82% increase from the reported $-107M in 2024. Projections indicate $-139M in 2026, $-158M in 2027, and $-16.272M in 2028.